Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Javier Valle to Time Factors

This is a "connection" page, showing publications Javier Valle has written about Time Factors.

 
Connection Strength
 
 
 
0.784
 
  1. Valle JA, Glorioso TJ, Schuetze KB, Grunwald GK, Armstrong EJ, Waldo SW. Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention. Circ Cardiovasc Interv. 2019 05; 12(5):e007636.
    View in: PubMed
    Score: 0.080
  2. Valle JA, Glorioso TJ, Maddox TM, Armstrong EJ, Waldo SW, Bradley SM, Ho PM. Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004623.
    View in: PubMed
    Score: 0.076
  3. Valle JA, Graham L, Thiruvoipati T, Grunwald G, Armstrong EJ, Maddox TM, Hawn MT, Bradley SM. Facility-level association of preoperative stress testing and postoperative adverse cardiac events. Heart. 2018 12; 104(24):2018-2025.
    View in: PubMed
    Score: 0.075
  4. Valle JA, Kaltenbach LA, Bradley SM, Yeh RW, Rao SV, Gurm HS, Armstrong EJ, Messenger JC, Waldo SW. Variation in the Adoption of Transradial?Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry. JACC Cardiovasc Interv. 2017 11 27; 10(22):2242-2254.
    View in: PubMed
    Score: 0.072
  5. Valle JA, McCoy LA, Maddox TM, Rumsfeld JS, Ho PM, Casserly IP, Nallamothu BK, Roe MT, Tsai TT, Messenger JC. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2017 Apr; 10(4).
    View in: PubMed
    Score: 0.069
  6. Valle JA, Shetterly S, Maddox TM, Ho PM, Bradley SM, Sandhu A, Magid D, Tsai TT. Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent Registry. Circ Cardiovasc Interv. 2016 06; 9(6).
    View in: PubMed
    Score: 0.065
  7. Valle JA, Zhang M, Dixon S, Aronow HD, Share D, Naoum JB, Gurm HS. Impact of pre-procedural beta blockade on inpatient mortality in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol. 2013 Jun 15; 111(12):1714-20.
    View in: PubMed
    Score: 0.052
  8. Kokkinidis DG, Jawaid O, Cantu D, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Armstrong EJ. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions. J Endovasc Ther. 2020 Jun; 27(3):492-501.
    View in: PubMed
    Score: 0.021
  9. Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes. Catheter Cardiovasc Interv. 2020 02 15; 95(3):439-446.
    View in: PubMed
    Score: 0.021
  10. Bricker RS, Glorioso TJ, Jawaid O, Plomondon ME, Valle JA, Armstrong EJ, Waldo SW. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2019 12 17; 8(24):e014906.
    View in: PubMed
    Score: 0.021
  11. Cantu D, Jawaid O, Kokkinidis D, Giannopoulos S, Valle JA, Waldo SW, Singh GD, Armstrong EJ. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease. Cardiovasc Revasc Med. 2020 07; 21(7):867-874.
    View in: PubMed
    Score: 0.021
  12. Ream K, Sandhu A, Valle J, Weber R, Kaizer A, Wiktor DM, Borne RT, Tumolo AZ, Kunkel M, Zipse MM, Schuller J, Tompkins C, Rosenberg M, Nguyen DT, Cleveland JC, Fullerton D, Carroll JD, Messenger J, Sauer WH, Aleong RG, Tzou WS. Ambulatory Rhythm Monitoring to?Detect?Late High-Grade Atrioventricular Block Following Transcatheter Aortic?Valve?Replacement. J Am Coll Cardiol. 2019 05 28; 73(20):2538-2547.
    View in: PubMed
    Score: 0.020
  13. Bricker RS, Valle JA, Plomondon ME, Armstrong EJ, Waldo SW. Causes of Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005355.
    View in: PubMed
    Score: 0.020
  14. Prouse AF, Langner P, Plomondon ME, Ho PM, Valle JA, Bar?n AE, Armstrong EJ, Waldo SW. Temporal trends in the management and clinical outcomes of lower extremity arterial thromboembolism within a national Veteran population. Vasc Med. 2019 02; 24(1):41-49.
    View in: PubMed
    Score: 0.019
  15. Waldo SW, Gokhale M, O'Donnell CI, Plomondon ME, Valle JA, Armstrong EJ, Schofield R, Fihn SD, Maddox TM. Temporal Trends in Coronary?Angiography and Percutaneous?Coronary?Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2018 05 14; 11(9):879-888.
    View in: PubMed
    Score: 0.019
  16. Sandhu A, Stanislawski MA, Grunwald GK, Guinn K, Valle J, Matlock D, Ho PM, Maddox TM, Bradley SM. Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program. J Am Heart Assoc. 2017 Sep 12; 6(9).
    View in: PubMed
    Score: 0.018
  17. Tsai TT, Stanislawski MA, Shunk KA, Armstrong EJ, Grunwald GK, Schob AH, Valle JA, Alfonso CE, Nallamothu BK, Ho PM, Rumsfeld JS, Brilakis ES. Contemporary Incidence, Management, and?Long-Term Outcomes of Percutaneous?Coronary Interventions for Chronic?Coronary Artery Total Occlusions: Insights From the VA CART?Program. JACC Cardiovasc Interv. 2017 05 08; 10(9):866-875.
    View in: PubMed
    Score: 0.017
  18. Armstrong EJ, Graham LA, Waldo SW, Valle JA, Maddox TM, Hawn MT. Incomplete Revascularization Is Associated With an Increased Risk for?Major Adverse Cardiovascular Events?Among Patients Undergoing Noncardiac Surgery. JACC Cardiovasc Interv. 2017 02 27; 10(4):329-338.
    View in: PubMed
    Score: 0.017
  19. Bradley SM, Liu W, Chan PS, Girotra S, Goldberger ZD, Valle JA, Perman SM, Nallamothu BK. Duration of resuscitation efforts for in-hospital cardiac arrest by predicted outcomes: Insights from Get With The Guidelines - Resuscitation. Resuscitation. 2017 04; 113:128-134.
    View in: PubMed
    Score: 0.017
  20. Hollis RH, Holcomb CN, Valle JA, Smith BP, DeRussy AJ, Graham LA, Richman JS, Itani KM, Maddox TM, Hawn MT. Coronary angiography and failure to rescue after postoperative myocardial infarction in patients with coronary stents undergoing noncardiac surgery. Am J Surg. 2016 Nov; 212(5):814-822.e1.
    View in: PubMed
    Score: 0.017
  21. Armstrong EJ, Graham L, Waldo SW, Valle JA, Maddox TM, Hawn MT. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Catheter Cardiovasc Interv. 2017 Mar 01; 89(4):617-627.
    View in: PubMed
    Score: 0.016
  22. Holcomb CN, Hollis RH, Graham LA, Richman JS, Valle JA, Itani KM, Maddox TM, Hawn MT. Association of Coronary Stent Indication With Postoperative Outcomes Following Noncardiac Surgery. JAMA Surg. 2016 05 01; 151(5):462-9.
    View in: PubMed
    Score: 0.016
  23. Gurm HS, Valle JA, Smith DE, Ellis SG. Eroding the denominator: the incomplete story of door-to-balloon time reporting. J Am Coll Cardiol. 2012 Aug 21; 60(8):789-90.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)